Cystic fibrosis (CF) is a genetic disease resulting in chronic polymicrobial infections of the airways and progressive decline in lung function. To gain insight into the underlying causes of severe lung diseases, we aimed at comparing the airway microbiota detected in sputum of CF patients with stable lung function (S) versus those with a substantial decline in lung function (SD). Microbiota composition was investigated by using culture-based and culture-independent methods, and by performing multivariate and statistical analyses. Culture-based methods identified some microbial species associated with a worse lung function, i.e. Pseudomonas aeruginosa, Rothia mucilaginosa, Streptococcus pneumoniae and Candida albicans, but only the presence of S. pneumoniae and R. mucilaginosa was found to be associated with increased severe decline in forced expiratory volume in 1 second (FEV1). Terminal-Restriction Fragment Length Polymorphism (T-RFLP) analysis revealed a higher bacterial diversity than that detected by culture-based methods. Molecular signatures with a statistically significant odds ratio for SD status were detected, and classified as Pseudomonas, Burkholderia and Shewanella, while for other Terminal Restriction Fragments (T-RFs) no species assignation was achieved. The analysis of T-RFLP data using ecological biodiversity indices showed reduced Evenness in SD patients compared to S ones, suggesting an impaired ecology of the bacterial community in SD patients. Statistically significant differences of the ecological biodiversity indices among the three sub-groups of FEV1 (normal/mild vs moderate vs severe) were also found, suggesting that the patients with moderate lung disease experienced changes in the airway assembly of taxa. Overall, changes in CF airway microbial community associated with a severe lung function decline were detected, allowing us to define some discriminatory species as well as some discriminatory T-RFs that represent good candidates for the development of predictive biomarkers of substantial decline in lung function. © 2015 Paganin et al.

Export Date: 4 June 2015CODEN: POLNCReferences: Taylor-Robinson, D., Whitehead, M., Diderichsen, F., Olesen, H.V., Pressler, T., Smyth, R.L., Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: A longitudinal study (2012) Thorax, 67, pp. 860-866. , PMID: 22555277;Kerem, E., Viviani, L., Zolin, A., MacNeill, S., Hatziagorou, E., Ellemunter, H., Factors associated with FEV1 decline in cystic fibrosis: Analysis of the ECFS Patient Registry (2014) Eur Respir J, 43, pp. 125-133. , PMID: 23598952; Rosenbluth, D.B., Wilson, K., Ferkol, T., Schuster, D.P., Lung function decline in cystic fibrosis patients and timing for lung transplantation referral (2004) Chest, 126, pp. 412-419. , PMID: 15302726; Sanders, D.B., Bittner, R.C.L., Rosenfeld, M., Hoffman, L.R., Redding, G.J., Goss, C.H., Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation (2010) Am J Respir Crit Care Med, 182, pp. 627-632. , PMID: 20463179; Konstan, M.W., Morgan, W.J., Butler, S.M., Pasta, D.J., Craib, M.L., Silva, S.J., Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis (2007) J Pediatr, 151, pp. 134-139. , PMID: 17643762; Milla, C.E., Warwick, W.J., Risk of death in cystic fibrosis patients with severely compromised lung function (1998) Chest, 113, pp. 1230-1234. , PMID: 9596299; Stressmann, F.A., Rogers, G.B., Klem, E.R., Lilley, A.K., Donaldson, S.H., Daniels, T.W., Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers (2011) J Clin Microbiol, 49, pp. 281-291. , PMID: 21068277; Huang, Y.J., Lynch, S.V., The emerging relationship between the airway microbiota and chronic respiratory disease: Clinical implications (2011) Expert Rev Respir Med, 5, pp. 809-821. , PMID: 22082166; Rogers, G.B., Shaw, D., Marsh, R.L., Carroll, M.P., Serisier, D.J., Bruce, K.D., Respiratory microbiota: Addressing clinical questions, informing clinical practice (2015) Thorax, 70, pp. 74-81. , PMID: 25035125; Rogers, G.B., Skelton, S., Serisier, D.J., Van Der Gast, C.J., Bruce, K.D., Determining cystic fibrosis-affected lung microbiology: Comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling (2010) J Clin Microbiol, 48, pp. 78-86. , PMID: 19906901; Lynch, S.V., Bruce, K.D., The cystic fibrosis airway microbiome (2013) Cold, 3, p. a009738. , Spring Harb Perspect Med. PMID: 23457293; Zhao, J., Murray, S., Lipuma, J.J., Modeling the impact of antibiotic exposure on human microbiota (2014) Sci Rep., 4, p. 4345. , PMID: 24614401; Mahenthiralingam, E., Emerging cystic fibrosis pathogens and the microbiome (2014) Paediatr Respir Rev., 15, pp. 13-15. , PMID: 24832700; Carmody, L.A., Zhao, J., Schloss, P.D., Petrosino, J.F., Murray, S., Young, V.B., Changes in cystic fibrosis airway microbiota at pulmonary exacerbation (2013) Ann Am Thorac Soc, 10, pp. 179-187. , PMID: 23802813; Hauser, A.R., Jain, M., Bar-Meir, M., McColley, S.A., Clinical significance of microbial infection and adaptation in cystic fibrosis (2011) Clin Microbiol Rev, 24, pp. 29-70. , PMID: 21233507; Sibley, C.D., Parkins, M.D., Rabin, H.R., Surette, M.G., The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis (2009) Curr Opin Investig Drugs, 10, pp. 787-794. , PMID: 19649923; Farrell, P.M., Rosenstein, B.J., White, T.B., Accurso, F.J., Castellani, C., Cutting, G.R., Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report (2008) J Pediatr, 153, pp. S4-S14. , PMID: 18639722; Kerem, E., Conway, S., Elborn, S., Heijerman, H., Standards of care for patients with cystic fibrosis: A European consensus (2005) J Cyst Fibros, 4, pp. 7-26. , PMID: 15996905; Flume, P.A., Mogayzel, P.J., Robinson, K.A., Goss, C.H., Rosenblatt, R.L., Kuhn, R.J., Cystic fibrosis pulmonary guidelines: Treatment of pulmonary exacerbations (2009) Am J Respir Crit Care Med, 180, pp. 802-808. , PMID: 19729669; Fuchs, H.J., Borowitz, D.S., Christiansen, D.H., Morris, E.M., Nash, M.L., Ramsey, B.W., Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis (1994) N Engl J Med, 331, pp. 637-642. , PMID: 7503821; Ramsey, B.W., Pepe, M.S., Quan, J.M., Otto, K.L., Montgomery, A.B., Williams-Warren, J., Intermittent administration of inhaled tobramycin in patients with cystic fibrosis (1999) N Engl J Med, 340, pp. 23-30. , PMID: 9878641; Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Standardisation of spirometry (2005) Eur Respir J, 26, pp. 319-338. , PMID: 16055882; Tunney, M.M., Field, T.R., Moriarty, T.F., Patrick, S., Doering, G., Muhlebach, M.S., Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis (2008) Am J Respir Crit Care Med, 177, pp. 995-1001. , PMID: 18263800; Burns, J.L., Emerson, J., Stapp, J.R., Yim, D.L., Krzewinski, J., Louden, L., Microbiology of sputum from patients at cystic fibrosis centers in the United States (1998) Clin Infect Dis, 27, pp. 158-163. , PMID: 9675470; Seng, P., Abat, C., Rolain, J.M., Colson, P., Lagier, J.C., Gouriet, F., Identification of rare pathogenic bacteria in a clinical microbiology laboratory: Impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry (2013) J Clin Microbiol, 51, pp. 2182-2194. , PMID: 23637301; Del Chierico, F., Masotti, A., Onori, M., Fiscarelli, E., Mancinelli, L., Ricciotti, G., MALDI-TOF MS proteomic phenotyping of filamentous and other fungi from clinical origin (2012) J Proteomics, 75, pp. 3314-3330. , PMID: 22504628; Bittar, F., Rolain, J.M., Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients (2010) Clin Microbiol Infect, 16, pp. 809-820. , PMID: 20880410; Rogers, G.B., Carroll, M.P., Serisier, D.J., Hockey, P.M., Jones, G., Bruce, K.D., Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling (2004) J Clin Microbiol, 42, pp. 5176-5183. , PMID: 15528712; McCafferty, J., Reid, R., Spencer, M., Hamp, T., Fodor, A., Peak Studio: A tool for the visualization and analysis of fragment analysis files (2012) Environ Microbiol Rep, 4, pp. 556-561. , PMID: 23760901; (2014) R: A Language and Environment for Statistical Computing, , http://www.R-project.org/, R Foundation for Statistical Computing, Vienna, Austria Available; Shyu, C., Soule, T., Bent, S.J., Foster, J.A., Forney, L.J., MiCA: A web-based tool for the analysis of microbial communities based on terminal-restriction fragment length polymorphisms of 16S and 18S rRNA genes (2007) Microb Ecol, 53, pp. 562-570. , PMID: 17406775; Zhao, J., Schloss, P.D., Kalikin, L.M., Carmody, L.A., Foster, B.K., Petrosino, J.F., Decade-long bacterial community dynamics in cystic fibrosis airways (2012) Proc Natl Acad Sci USA, 109, pp. 5809-5814. , PMID: 22451929; Vandenbranden, S.L., McMullen, A., Schechter, M.S., Pasta, D.J., Michaelis, R.L., Konstan, M.W., Lung function decline from adolescence to young adulthood in cystic fibrosis (2012) Pediatr Pulmonol, 47, pp. 135-143. , PMID: 22241571; Cazzola, M., MacNee, W., Martinez, F.J., Rabe, K.F., Franciosi, L.G., Barnes, P.J., Outcomes for COPD pharmacological trials: From lung function to biomarkers (2008) Eur Respir J, 31, pp. 416-468. , PMID: 18238951; Emerson, J., Rosenfeld, M., McNamara, S., Ramsey, B., Gibson, R.L., Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis (2002) Pediatr Pulmonol, 34, pp. 91-100. , PMID: 12112774; Saiman, L., Siegel, J.D., LiPuma, J.J., Brown, R.F., Bryson, E.A., Chambers, M.J., Infection prevention and control guidelines for cystic fibrosis: 2013 Update (2014) Infect Control Hosp Epidemiol, 35, pp. S1-S67; Foweraker, J., Recent advances in the microbiology of respiratory tract infection in cystic fibrosis (2009) Br Med Bull, 89, pp. 93-110. , PMID: 19155262; Maeda, Y., Elborn, J.S., Parkins, M.D., Reihill, J., Goldsmith, C.E., Coulterf, W.A., Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF) (2011) J Cyst Fibros, 10, pp. 133-139. , PMID: 21145793; Bittar, F., Richet, H., Dubus, J.C., Reynaud-Gaubert, M., Stremler, N., Sarles, J., Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients (2008) PLoS One. Public Library of Science, 3, p. e2908. , PMID: 18682840; Guss, A.M., Roeselers, G., Newton, I.L.G., Young, C.R., Klepac-Ceraj, V., Lory, S., Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis (2011) ISME J, 5, pp. 20-29. , PMID: 20631810; Lim, Y.W., Schmieder, R., Haynes, M., Furlan, M., Matthews, T.D., Whiteson, K., Mechanistic model of Rothia mucilaginosa adaptation toward persistence in the CF lung, based on a genome reconstructed from metagenomic data (2013) PLoS One. Public Library of Science, 8, p. e64285; Chotirmall, S.H., O’Donoghue, E., Bennett, K., Gunaratnam, C., O’Neill, S.J., McElvaney, N.G., Sputum Candida albicans presages FEV1 decline and hospital-treated exacerbations in cystic fibrosis (2010) Chest, 138, pp. 1186-1195. , PMID: 20472859; Bevivino, A., Bragonzi, A., The evolving polymicrobial composition in the airways of patients with cystic fibrosis: Implications for disease progression and clinical management (2013) CML Cystic Fibrosis, 3, pp. 93-104; Liu, W.T., Marsh, T.L., Cheng, H., Forney, L.J., Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA (1997) Appl Environ Microbiol, 63, pp. 4516-4522. , PMID: 9361437; Osborn, A.M., Moore, E.R., Timmis, K.N., An evaluation of terminal-restriction fragment length polymorphism (T-RFLP) analysis for the study of microbial community structure and dynamics (2000) Environ Microbiol, 2, pp. 39-50. , PMID: 11243261; Marsh, T.L., Jared, R.L., Culture-independent microbial community analysis with terminal restriction fragment length polymorphism (2005) Methods Enzymol, 397, pp. 308-329. , PMID: 16260299; Tiquia, S.M., Using terminal restriction fragment length polymorphism (T-RFLP) analysis to assess microbial community structure in compost systems (2010) Methods Mol Biol, 599, pp. 89-102. , PMID: 19882281; Joo, S., Lee, S.-R., Park, S., Monitoring of phytoplankton community structure using terminal restriction fragment length polymorphism (T-RFLP) (2010) J Microbiol Methods, 81, pp. 61-68. , PMID: 20138925; Nakano, Y., Takeshita, T., Yasui, M., Yamashita, Y., Prediction of plausible bacterial composition based on terminal restriction fragment length polymorphisms using a Monte Carlo method (2010) Microb Ecol, 60, pp. 364-372. , PMID: 20574825; Rogers, G.B., Hart, C.A., Mason, J.R., Hughes, M., Walshaw, M.J., Bruce, K.D., Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling (2003) J Clin Microbiol, 41, pp. 3548-3558. , PMID: 12904354; Sibley, C.D., Parkins, M.D., Rabin, H.R., Duan, K., Norgaard, J.C., Surette, M.G., A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients (2008) Proc Natl Acad Sci USA, 105, pp. 15070-15075. , PMID: 18812504; Camarinha-Silva, A., Wos-Oxley, M.L., Jáuregui, R., Becker, K., Pieper, D.H., Validating T-RFLP as a sensitive and high-throughput approach to assess bacterial diversity patterns in human anterior nares (2012) FEMS Microbiol Ecol, 79, pp. 98-108. , PMID: 22066869; Filkins, L.M., Hampton, T.H., Gifford, A.H., Gross, M.J., Hogan, D.A., Sogin, M.L., Prevalence of Streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability (2012) J Bacteriol, 194, pp. 4709-4717. , PMID: 22753064; Cai, L., Ye, L., Tong, A.H.Y., Lok, S., Zhang, T., Biased diversity metrics revealed by bacterial 16S pyrotags derived from different primer sets (2013) PLoS One. Public Library of Science, 8, p. e53649; Taberlet, P., Coissac, E., Pompanon, F., Brochmann, C., Willerslev, E., Towards next-generation biodiversity assessment using DNA metabarcoding (2012) Mol Ecol, 21, pp. 2045-2050. , PMID: 22486824; Maughan, H., Wang, P.W., Diaz Caballero, J., Fung, P., Gong, Y., Donaldson, S.L., Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions (2012) PLoS One. Public Library of Science, 7, p. e45791. , PMID: 23056217; Lim, Y.W., Evangelista, J.S., Schmieder, R., Bailey, B., Haynes, M., Furlan, M., Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis (2014) J Clin Microbiol, 52, pp. 425-437. , PMID: 24478471; Blackwood, C.B., Hudleston, D., Zak, D.R., Buyer, J.S., Interpreting ecological diversity indices applied to terminal restriction fragment length polymorphism data: Insights from simulated microbial communities (2007) Appl Environ Microbiol, 73, pp. 5276-5283. , PMID: 17601815; Ding, T., Palmer, M.W., Melcher, U., Community terminal restriction fragment length polymorphisms reveal insights into the diversity and dynamics of leaf endophytic bacteria (2013) BMC Microbiol, 13, p. 1. , PMID: 23286760